Successful fertility preservation following ovarian tissue vitrification in patients with primary ovarian insufficiency

Human Reproduction

Volumn 30, Issue 3, 2015, Pages 608-615

  Suzuki, Nao ^a   Yoshioka, Nobuhito ^a   Takae, Seido ^a   Sugishita, Yodo ^a   Tamura, Midori ^a   Hashimoto, Shu ^b   Morimoto, Yoshiharu ^b   Kawamura, Kazuhiro ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b IVF Namba Clinic   (Japan)

Author keywords

Akt stimulation; In vitro activation; Infertility treatment; Ovarian tissue vitrification; Primary ovarian insufficiency

Indexed keywords

CHORIONIC GONADOTROPIN; ESTROGEN; FOLLITROPIN; MUELLERIAN INHIBITING FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B;

ADULT; AMENORRHEA; ARTICLE; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRYOPRESERVATION; DELIVERY; EMBRYO TRANSFER; ENZYME ACTIVATION; ESTROGEN BLOOD LEVEL; FEMALE; FEMALE INFERTILITY; FERTILITY PRESERVATION; FOLLITROPIN BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; HUMAN TISSUE; LAPAROSCOPIC SURGERY; OOCYTE RETRIEVAL; OVARIECTOMY; OVARY FOLLICLE; PREMATURE OVARIAN FAILURE; PROSPECTIVE STUDY; SPONTANEOUS ABORTION; UTERINE TUBE; VITRIFICATION; GROWTH, DEVELOPMENT AND AGING; INFERTILITY, FEMALE; OVARY; PHYSIOLOGY; PREGNANCY; PREGNANCY OUTCOME; PRIMARY OVARIAN INSUFFICIENCY; PROCEDURES; TRANSPLANTATION;

ANIMALIA;

ADULT; CRYOPRESERVATION; FEMALE; FERTILITY PRESERVATION; HUMANS; INFERTILITY, FEMALE; OVARIAN FOLLICLE; OVARY; PREGNANCY; PREGNANCY OUTCOME; PRIMARY OVARIAN INSUFFICIENCY; PROSPECTIVE STUDIES; VITRIFICATION;

EID: 84933527620     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/deu353     Document Type: Article

References (30)

1. Amorim CA, Curaba M, Van Langendonckt A, Dolmans MM, Donnez J. Vitrification as an alternative means of cryopreserving ovarian tissue. Reprod Biomed Online 2011;23:160-186.
2. Andersen CY, Kristensen SG, Greve T, Schmidt KT. Cryopreservation of ovarian tissue for fertility preservation in young female oncological patients. Future Oncol 2012;8:595-608.
3. Broekmans FJ, Soules MR, Fauser BC. Ovarian aging: mechanisms and clinical consequences. Endocr Rev 2009;30:465-493.
4. Callejo J, Salvador C, Gonzalez-Nunez S, Almeida L, Rodriguez L, Marques L, Valls A, Lailla JM. Live birth in a woman without ovaries after autograft of frozen-thawed ovarian tissue combined with growth factors. J Ovarian Res 2013;6:33.
5. De Vos M, Devroey P, Fauser BC. Primary ovarian insufficiency. Lancet 2010; 376:911-921.
6. Demeestere I, Simon P, Emiliani S, Delbaere A, Englert Y. Orthotopic and heterotopic ovarian tissue transplantation. Hum Reprod Update 2009; 15:649-665.
7. Donnez J, Dolmans MM. Cryopreservation and transplantation of ovarian tissue. Clin Obstet Gynecol 2010;53:787-796.
8. Donnez J, Dolmans MM, Demylle D, Jadoul P, Pirard C, Squifflet J, Martinez-Madrid B, van Langendonckt A. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 2004;364: 1405-1410.
9. Gamzatova Z, Komlichenko E, Kostareva A, Galagudza M, Ulrikh E, Zubareva T, Sheveleva T, Nezhentseva E, Kalinina E. Autotransplantation of cryopreserved ovarian tissue-effective method of fertility preservation in cancer patients. Gynecol Endocrinol 2014;30(Suppl 1):43-47.
10. Grynberg M, Poulain M, Sebag-Peyrelevade S, le Parco S, Fanchin R, Frydman N. Ovarian tissue and follicle transplantation as an option for fertility preservation. Fertil Steril 2012;97:1260-1268.
11. Hashimoto S, Suzuki N, Yamanaka M, Hosoi Y, Ishizuka B, Morimoto Y. Effects of vitrification solutions and equilibration times on the morphology of cynomolgus ovarian tissues. Reprod Biomed Online 2010; 21:501-509.
12. Ishizuka B, Kudo Y, Amemiya A, Ogata T. Ovulation induction in a woman with premature ovarian failure resulting from a partial deletion of the X chromosome long arm, 46, X, del(X)(q22). Fertil Steril 1997;68:931-934.
13. Jeong K, Aslan E, Ozkaya E, Sonmezer M, Oktay K. Ovariancryopreservation. Minerva Med 2012;103:37-46.
14. Kagawa N, Silber S, Kuwayama M. Successful vitrification of bovine and human ovarian tissue. Reprod Biomed Online 2009;18:568-577.
15. Katayama KP, Stehlik J, Kuwayama M, Kato O, Stehlik E. High survival rate of vitrified human oocytes results in clinical pregnancy. Fertil Steril 2003; 80:223-224.
16. Kawamura K, Cheng Y, Suzuki N, Deguchi M, Sato Y, Takae S, Ho CH, Kawamura N, Tamura M, Hashimoto S et al. Hippo signaling disruption and Akt stimulation of ovarian follicles for infertility treatment. Proc Natl Acad Sci USA 2013;110:17474-17479.
17. Kolp LA, Hubayter Z. Autotransplantation of cryopreserved ovarian tissue: a procedure with promise, risks, and a need for a registry. Fertil Steril 2011; 95:1879-1886.
18. Kuwayama M. Highly efficient vitrification for cryopreservation of human oocytes and embryos: the Cryotop method. Theriogenology 2007; 67:73-80.
19. Kuwayama M, Vajta G, Kato O, Leibo SP. Highly efficient vitrification method for cryopreservation of human oocytes. Reprod Biomed Online 2005; 11:300-308.
20. Li J, Kawamura K, Cheng Y, Liu S, Klein C, Liu S, Duan EK, Hsueh AJ. Activation of dormant ovarian follicles to generate mature eggs. Proc Natl Acad Sci USA 2010;107:10280-10284.
21. Loren AW, Mangu PB, Beck LN, Brennan L, Magdalinski AJ, Partridge AH, Quinn G, Wallace WH, Oktay K. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 2013;31:2500-2510.
22. McGrath SA, Esquela AF, Lee SJ. Oocyte-specific expression of growth/differentiation factor-9. Mol Endocrinol 1995;9:131-136.
23. Meirow D, Levron J, Eldar-Geva T, Hardan I, Fridman E, Zalel Y, Schiff E, Dor J. Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. N Engl J Med 2005; 353:318-321.
24. Menon V, Edwards RL, Lynch SS, Butt WR. Luteinizing hormone releasing hormone analogue in treatment of hypergonadotrophic amenorrhoea. Br J Obstet Gynaecol 1983;90:539-542.
25. Nelson LM. Clinical practice. Primary ovarian insufficiency. NEngl JMed 2009; 360:606-614.
26. Nelson LM, Anasti JN, Kimzey LM, Defensor RA, Lipetz KJ, White BJ, Shawker TH, Merino MJ. Development of luteinized Graafian follicles in patients with karyotypically normal spontaneous premature ovarian failure. J Clin Endocrinol Metab 1994;79:1470-1475.
27. Suzuki N, Hashimoto S, Igarashi S, Takae S, Yamanaka M, Yamochi T, Takenoshita M, Hosoi Y, Morimoto Y, Ishizuka B. Assessment of long-term function of heterotopic transplants of vitrified ovarian tissue in cynomolgus monkeys. Hum Reprod 2012;27:2420-2429.
28. Taylor RN, Lebovic DI, Mueller MD. Angiogenic factors in endometriosis. Ann N Y Acad Sci 2002;955:89-100; discussion 118, 396-406.
29. von Wolff M, Donnez J, Hovatta O, Keros V, Maltaris T, Montag M, Salle B, Sonmezer M, Andersen CY. Cryopreservation and autotransplantation of human ovarian tissue prior to cytotoxic therapy-a technique in its infancy but already successful in fertility preservation. Eur J Cancer 2009; 45:1547-1553.
30. Weenen C, Laven JS, Von Bergh AR, Cranfield M, Groome NP, Visser JA, Kramer P, Fauser BC, Themmen AP. Anti-Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod 2004;10:77-83.